Member Info for BoNidel

Big volume, big news going into the 4th July weekend?

You may well be right. Volume isn’t as high as it was but it’s up a lot more than last few years aside from 2 years ago.

I think the next week or two we will see some major price movement upwards. Momentum is what this has lacked and I think it could be coming. Especially given we have actually had some news and updates this year. A couple of decent weeks and the current SP could be left in the dust. A fund raise must surely be on the cards unless they are planning to uplist on to the Nasdaq capital market (or whatever it was). Wendy Blossers bonus was conditional on a $30m fundraise (unless this has changed) so I would assume they are trying to get as much cash for as little dilution as possible. If it’s genuinely commercially competitive then it may well suit an institution or another company to JV or swallow accustem rather than short term cash. Ideally want someone onboard that will pay a decent amount without crazy dilution but then they get a decent pull out of it long term.

Either that or acquisition. Their previous literature always stressed it was an acquisition target. We may well see that it is.

$280m valuation they put on it previously, now there are more products.

That’s almost 20x where we are now in MCAP terms.

I’m sick and tired of accustem/tiziana and the whole debacle but I think after the massive wait we could be just about to head in to the golden period (if you’re a shareholder at decent prices) for accustem.

That’s 9 different buys in the last 6 months. I know he had a pile of free shares in lieu of salary which I didn’t like but the MSC Deal may have been decent.

Still bought over 330,000 shares on the open market this last 6 months which has got to be way north of $150,000 dollars into a penny stock. It’s fairly lumpy. I wonder if we will look back and see that the signs were always there! Don’t want to ramp this as it has annoyed me for so many years

No, it was a clone of the previous MSC press release.

Got to mean something. Hasn’t been the first time. Let’s see what happens this week, I wish I bought a lot more last week. I could sense this coming.

That we get a big PR about uplisting or a deal or something else that send the price through the roof?

Up 182% last 12 months and 358% last 6 months.

I don’t want to say it as I’m furious with the handling of it for years but this looks like it is about to explode now.

There you go. He’s bought another 9000 ish shares. Increases his holding again. He’s bought somewhere near 300,000 shares on the open market in the last 6 months at a cost of probably $150k ish? It’s a fair sized amount of director buying for an OTC Penny stock, that’s for sure. Considering increasing again here but I’ve bought a hell or a lot since the demerger even though it’s really annoyed me, I like the principle of the company. It doesn’t feel like a Fad like a lot of the other small cap companies I’ve been in

0.8647 now and we are touching 20k volume for the day.

Here it comes again.

Bid is now 0.8

I knew this was coming at some stage. Is it GC buying again or someone else?

Even with the dilution, the MCAP of this is up like 100% or more the past few months?

You wait and see some big news drop now or a lump of funding of some sort or another investor or something to do with Emeritus DX.

There was a clone press release last week that got removed on the OTC Market news (maybe from globenewswire?) and I think this was news that was setup to be released and then pulled.

We previously had a $3 share price here and have seen I think $25m mcap I think it was about 18 months or 2 years ago (forgive me if I’m wrong).

My target is $25m mcap before the end of this year. Maybe even before the end of the summer.

Also depends on wider market forces. The ARKG index and XBI have bounced back up again recently. If biotech comes ha o & this pops it could be the perfect storm…

Some buys through at 0.848 now as well today.

Seriously wonder if this is the last chance to buy accustem so cheap.

Although I’ve got a substantial holding I’m considering buying more. After the 4 year wait or whatever it is I am loathed to have any faith in it now but if it’s genuine and some more news starts to follow I can see this straight to 30/40m mcap which is 2-3x where we are today

My gut tells me some big news may well be due soon.

No sure what’s going on here now,

Was showing as 12,100,535 for ages, then 16,182,848 shares out when I updated recently,

Then 16,604,535 yesterday and now today 15,972,267 shares out.

Like wtf!

Now at 16,182,848

The placing was for 3,750,000 for the MSC acquisition. The previous shares out were 12,100,535 if I remember correctly, so where have the additional come from?

Or is this a seperate amount of funding? Are we about to receive an RNS about further dilution? Is it positive?

More updates needed please. Especially after the 4 year wait

More today surrounding commercialisation of MSC.

When will we hear about Stemprinter and funding?

Lots of news flowing from accustem the last few months.

Maybe we will get some bigger announcements soon and start to see positive price action

Another 5000 buy. I make that 5 or 6 buys since the latter end of last year. Touching 295k shares (plus the 740k odd he had in lieu of his “consulting” fees due).

Either we are being shafted here or value is going to be delivered and GC is getting what he deserves if he’s done a bumper deal.

You know how I feel about the whole situation over the last few years. Maybe sentiment will change with accustem and Tiziana if there’s a decent outcome

Chairman I should say as opposed to director.

Nonetheless, another 38k purchased.

What is the game here? We have had plenty of buys before but not much news, funding is obviously difficult but surely they need something if they plan to commercialise next year?…

Looks like GC has bought some more shares again.

100k on March 18th

52k April 7th.

Maybe some more yesterday also looking at the volume.

Director buys are never a bad thing really. Let’s see how the market reacts here. Is accustem finally waking up to deliver longer term share holder value? Finally?

It’s not just that, it’s the fact he took them at perhaps the lowest prices that Accustem has been since its inception. 754,000 shares or somewhere near to cover somewhere near $180k of consulting fees.

6% dilution to cover GC’s consulting.

I don’t disagree the MSC deal could well be a decent one and if he is delivering exceptional shareholder value then so be it, I’m not lop-sided in thinking everyone is equal here but we still don’t seem to have the funding in place.

Perhaps the news will start to flow here now.

I notice some large buys yesterday @ 0.65 so am wondering if he has increased his stake again. The larger buys are normally from GC so let’s wait and see.

If this is truly commercialising in 2026 we need to see funding and more updates very shortly.

Gabrielle cerrone took another 700,000 odd shares in lieu of payment for his “consulting fee”.

Dilution of somewhere near 6% for the “consulting” to the firm.

He now owns about 39% again. The whole thing just stinks in my opinion. I honestly cannot believe it.

Have a read of the recent 10k.

With Tiziana & GC shares the owneship is less than 50% now in public

Is 5x what it was for a considerable period of time.

The 0.45-0.50 level looks pretty stable to move off currently.

Here’s to hoping some decent news is due relating to funding, commercialisation and any other agreements they may have. Also, the 10k form explaining the additional 700k (or whatever it was) GC has acquired which correlates to the increase in accustem shares in issue. Did he do a private placing? Is that possible?

How are the staff being paid? Joe Flanagan & Wendy Blosser have $600k+ salary + bonus minimum as it’s, without the other running costs.